Microspheres - Novel Drug Delivery Carrier for Plant Extracts for Antibacterial Activity
Jobin Jose1, Dhidhin Raju1, Prashanth Nayak1
1Department of Pharmaceutics, N.G.S.M. Institute of Pharmaceutical Sciences, Nitte University, Paneer, Deralakatte, Mangalore - 575 018
*Corresponding Author E-mail: prashantn2001@yahoo.co.in
ABSTRACT:
Last several years, great advances had taken part in development of novel drug delivery system in plant extracts and active moieties. The various disadvantages associated with the conventional therapy can be surmount by means of well- controlled novel drug delivery system and also enhances patient compliance. Such systems deliver optimum amount of drug at correct time, cause less toxicity and minimal side effects. Microspheres are very small spherical particles, which is having diameter in the micrometer range mostly 1μm -1000μm. In microspheres, drugs are dispersed as crystalline or finely divided form. The herbal formulations are also incorporated to microspheres. This review highlights the importance of microspheres as a drug delivery carrier for plant extracts for antibacterial activity.
KEYWORDS: Novel drug delivery system, Microspheres, Plant extracts.
INTRODUCTION:
There are different novel drug delivery carriers like microspheres, nanoparticles, nano capsules, liposomes, phytosomes, nano emulsions, ethosomes and transferosomes are available for herbal formulations. Main advantages of novel herbal formulation are less toxicity, improved solubility, enhancement of bioavailability, protection from degradation, controlled drug release, improved stability and better therapeutic efficiency.
Bacterial infections in skin:
Most of the people in the universe are suffering from bacterial skin infections. This is one of the common problems which encountered in the clinical practice. The bacterial skin infections which caused by the bacteria, mainly the gram positive and gram negative bacteria1.
The gram positive bacteria which includes Staphylococcus aureus A and B, Streptococcus viridans and Enterococcus faecalis.
The gram negative bacteria that which effect very less that are Capnocytophaga species, Haemophilus influenza, Pasteurella multocida, Mycobacterium species, Proteus species, Pseudomonas species and other anaerobes. Staphylococcus aureas, one of major species in bacteria which mainly causes the bacterial skin infections2. Styphylocccus aureus and streptococcus pyrogens are the commonly recognized sources of skin infections.
Nair A et.al studied skin and soft tissue infections (SSTIs) are mainly caused by Staphylococcus aureus and streptococcus pyogens. SSTIs are caused by methicillin-resistant Staphylococcus aureus (MRSA) and multidrug resistance is common for both community-associated (CA)-MRSA and health associated (HA)-MRSA infections3.
Herbal medicines for the treatment of bacterial infections in skin:
In the current years, our medicinal practices were largely dominated by plant based medicines. In the contrast, many developing nations continued to benefit from the rich knowledge of medicinal herbalism. The various advantages of herbal medicines are lesser side effects, low cost, wide spread availability and effectives with chronic conditions. Kulkarni GT et.al studied that plant based drugs are used for many ailments but is having some stability issues and also poor lipid solubility. So that in order to overcome these problems herbal novel drug delivery system for phytomedicines have emerged. Herbal novel drug delivery system includes liposomes, phytosomes, ethosomes, transferosomes and particulate delivery systems includes microspheres, micropellets, nanoparticles and micro - nano emulsions. When herbal drugs incorporated to this system it improved stability, bioavailability and reduce toxicity4. Thillaivanan S et.al, conducted the study regarding the constraints, opportunities and challenges regarding the herbal medicines. In developing and developed countries, the herbal medicine is used widely in past years. According to the studies the herbal medicines have lesser side effects when compared to the conventional medicines5.
Microspheres:
Microspheres are very small spherical particles, which is having diameter in the micrometer range mostly 1μm -1000μm6. Natural polymers and synthetic polymers are used for the preparation of microspheres. In microspheres, drugs are dispersed as crystalline or finely divided form7.
Figure 1. Classification of microspheres.
Types of Microspheres
1 Bio adhesive microspheres
2 Magnetic microspheres
3 Radioactive microspheres
4 Floating microspheres
5 Polymeric microspheres
a) Biodegradable polymeric microspheres
b) Synthetic polymeric microspheres
1. Bio adhesive microspheres:
Bio adhesive microspheres, it will adhere to the mucosal membrane such as ocular, rectal, buccal etc. This adhesion is due to the sticking property of polymer8. In these types of microspheres produces better and enhanced therapeutic efficiency due to its prolonged contact at the site of application9.
2. Magnetic microspheres:
This is another important class of microspheres because it localizes drug towards the disease site10. In this, there are many magnetic carriers which will receive magnetic responses to magnetic field from the incorporated materials11. In this only less amount of drug is required, because magnetically targeted drugs are used12.
3. Radioactive microspheres:
These types of microspheres are more effective in case of tumors. After injecting in to the arteries, the radioactive microspheres exactly located into cancerous tissue and deliver the radiation without affecting the normal tissues13.
4. Floating microspheres:
The bulk density of floating microspheres is less than that of gastric fluid so that it will float in stomach. In this type, drugs are given as floating microspheres and it is having prolonged therapeutic effect14. In these types of microspheres showed enhanced gastric residence time due to its floating nature and slow drug release. Another advantage of floating microspheres is reduced dose dumping15.
5. Polymeric microspheres:
It can be classified into two
a) Biodegradable polymeric microspheres:
Starch is biodegradable as well as bio adhesive in nature. Here microspheres showed high residence time due to its prolonged contact with the mucous membrane16. They will easily convert to gel form because of its swelling nature in water. The main disadvantage of degradable polymer microspheres are low drug loading efficiency and drug release is difficult to control17.18.
b) Synthetic polymeric microspheres:
It is mostly used as fillers, drug delivery vehicles etc. and it’s having wide clinical applications but in these types of microspheres, it is having chances of moving away from the site of injection and leads to embolism, organ damage etc19.
Ideal Characteristics of Microspheres:
· It should incorporate reasonably high concentration of drug.
· Controlled particle size and solubility in aqueous vehicles for injection.
· Biocompatibility with a controllable biodegradability.
· It should be stable with satisfactory shelf life.
· Control release of the drug over long period.
General Methods of Preparation of Microspheres:
1. Spray Drying:
In this polymer is dissolved in suitable solvents such as acetone, dichloromethane etc20. Solid form of drug then dispersed in the above solution by the help of high-speed homogenization and atomized in hot air. After atomization, solvent evaporates it will results in the formation of small droplets (1-100μm). During this procedure, traces of solvent can be removed by vacuum drying and micro particles are removed by using cyclone separator21.
2. Solvent evaporation:
Solvent evaporation is mainly carried out in liquid vehicle phase and this microcapsule coating will dispersed in the volatile solvent22. For microencapsulation, core material is dispersed in coating polymer solution. The core material is dissolved in liquid manufacturing vehicle phase to get particular size of microcapsule23,24. Core materials are of two types i.e., water soluble as well as water insoluble materials, if core is soluble in polymer solution then it is matrix type microcapsule. Solvent evaporation is the one of the method which widely used in the preparation of microspheres25.
3. Single emulsion techniques:
The process involves dissolving of natural polymers in aqueous phase and then dispersion is transferred in to a non aqueous phase and finally cross linking of dispersed globule will occur. The cross linking can occur either by chemical cross linkers or by heat26. Chemical cross linkers such as formaldehyde are used for heat sensitive substances. But drawback of chemical cross linker is that more exposure of chemicals to the active pharmaceutical ingredients at the time of manufacturing27.
4. Double emulsion techniques:
In this technique, multiple emulsion of type w/o/w is formed. This techniques most useful in case of water soluble drugs, proteins, peptides, vaccines, etc. Here both natural and synthetic polymers can be used28.
5. Phase separation coacervation technique:
In this method, coacervates are formed. Coacervates are polymer rich phase formed by decreasing solubility of polymer in the organic phase. Here incompatible polymer is added to the solution of polymer, where the drug particles are dispersed in it and non-solvent is added for solidification of polymer. In this process, the formation of coacervates determines rate of polymer film distribution, particle size etc. The agglomerates are avoided using high speed stirring and this will results in microsphere formation29.
6. Spray drying and spray congealing:
In this method, polymers are dissolved in suitable volatile organic solvent such as acetone, dichloromethane. Under high speed homogenization, the drug is then dispersed in polymer solution. This dispersion is atomized in a steam of hot air. This will results the formation of the small droplets due to atomization17.
7. Solvent Extraction:
This method is used in manufacturing of microspheres. In this method, organic phase is removed by means of extraction with non-aqueous solvent. Here water miscible organic solvent such as isopropanol is used mainly30. In this process, the holding time for microspheres decreases. The organic phase can be easily removed by extraction with water. The one and only difference of this process is direct incorporation of drug or protein to polymer organic solution18. The solvent removal rate by this process depends on temperature, solubility profile of polymers and ratio of emulsion volume to the water 19.
8. Quassi emulsion solvent diffusion:
This method is used for the manufacturing of micro sponges and controlled release microspheres. Controlled release microspheres are usually prepared with acrylic polymer31. It consists of two phases. Internal phase is prepared at 600C. Here external phase is added to internal phase at room temperature. Then stirred for 2 h after formation of emulsion and then filtered to separate micro sponges, then it is washed and dried in vacuum20.
General Applications21, 22, 23
· The solubility of poorly soluble drug can be increased by means of particle size reduction.
· It provides prolonged therapeutic effect and decreases toxicity.
· Constant drug concentration in blood can be achieved.
· It prevents the drug from photolytic and enzymatic cleavage so it is found to be the best for the drug delivery of proteins.
· It helps to mask the unpleasant taste by converting liquid to solid form.
· Can delay volatilization.
· Use for ophthalmic, nasal, buccal, gastrointestinal, transdermal, colonic, vaginal drug delivery
Evaluation of Microspheres:
1. Particle shape and size:
It is usually observed by means of scanning electron microscopy (SEM)12,32.
2. Density determination:
Density of microsphere is determined by using multi volume pycnometer13.
3. Isoelectric point:
Isoelectric point is determined by micro electrophoresis and the electrophoretic mobility of microspheres is measured during this process 14,33.
4. Swelling index:
It can be calculated from the following formula,
Swelling index = *100.
5. Drug entrapment efficiency:
It is calculated by using the following formula34,
% entrapment = ×100
CONCLUSION :
This review highlighted the importance of microspheres as a novel drug delivery carrier for plant extracts for antibacterial activity. The herbal drugs can be in cooperated to the microspheres for the better release of the drug and also better entrapment efficiency which in turn enhances the therapeutic efficiency
REFERENCES:
1 Templer SJ, Maximo O. Bacterial skin and soft tissue infections; Clinical Review.2009;6(3):21-28.
2 Ueda CT. Topical and Transdermal Drug Products. International Journal of Pharmaceutical Sciences.2009;35(3):750-764.
3 Nair A, Jacob S, Al-Dhubiab B ,Harsha S. Basic considerations in the dermatokinetics of topical formulations. Brazillian Journal of Pharmaceutical Sciences.2013; 49(3):423-434.
4 Kulkareni GT. Herbal drug delivery systems: An emerging area in herbal drug research. Journal of Chronotherapy and Drug Delivery.2011;2(3):113-19.
5 Thillaivanan S, Samraj K. Challenges, constraints and opportunities in herbal medicines-a review. The Journal of Herbal Medicine. 2014;2(1):21-24.
6 Kaur LP, Guleri TK. Topical Gel: A recent approach for novel drug delivery. Asian Journal of Biomedical and Pharmaceutical Sciences.2013;3(17):1-5.
7 Dehghan S. Formulation optimization of Nifedipine containing microspheres using factorial design. African Journal of Pharmacy and Pharmacology.2010;4(6):346-354.
8 Jose J, Charyulu RN, Nayak P. In vitro cytotoxicity studies of PAMAM dendrimer with an antifungal agent. Research Journal of Pharmacy and Technology.2016; 9(1):17-19.
9 Majeti NV, Kumar R. Nano and micro particles as controlled drug delivery device. Journal of pharmaceutical sciences.2000;3(2):234-58.
10 AlagusundaramM, Chetty M, Umashankari K, BadarinathAV, Lavanya C. Microspheres as a novel drug delivery sysytem - a review. International Journal of ChemTech Research. 2009;(1):526-34.
11 Hosadurga RR, Rao SN, Jose J, Charyulu RN. Evaluation of the efficacy of 2% curcumin gel in the treatment of experimental periodontitis. Pharmacognosy Research.2014; 6 (6): 326-333.
12 Kaur P, Kaur L, Khan MU. Topical formulations and Hydro-gel: An overview. International Journal of Current Research.2013;2(1):201-06.
13 Chittodiya P, Tomar RS, Ramchandani U, Manocha N, Agrawal S. Topical Gel -A Review. International Journal of pharma and bio sciences2013;4(4):606 – 613.
14 Dehghan S. Formulation optimization of nifedipine containing microspheres using factorial design. African Journal of Pharmacy and Pharmacology.2010;4(6):346-354.
15 Kumar K, Pant NC, Ahmad S, Fatech MV. Development and evaluation of floating microspheres of curcumin. International Journal of Pharmacy and Pharmaceutical Sciences.2012;11(5):713-719.
16 Patel SK. Preparation and evaluation of chitosan microspheres containing nicorandil. International Journal of Pharmaceutical Science Invention.2014;4(1):32–37.
17 Buzia OD, Firescu D, Lancu M. Preparation and characterization of chitosan microspheres for vancomycin delivery. Farmacia.2015; 63(6):897-902.
18 Gholap SB, Banarjee SK, Gaikwad DD, Jadhav SL. Hollow microsphere: a review, International Journal of Pharmaceutical Sciences Review and Research. 2010;1:10-15.
19 Sudha MT, Naveen Kumar K. At preparation and evaluation of ethyl cellulose microspheres of ibuprofen for sustained drug delivery. International Journal of Pharma Research and Development. 2010;2(8):120-121.
20 Thanoo BC, Sunny MC, Jayakrishnan A. Cross-linked chitosan microspheres: Preparation and evaluation as a matrix for the controlled release of pharmaceuticals. Journal of Pharmacy and Pharmacology. 1992; 44:283-286.
21 Parmar H, Bakliwal S. Different method of evaluation of mucoadhesive microspheres. International Journal of Applied Biology and Pharmaceutical Technology. 2010;1(3):1164-1165.
22 Kavita K, Raje VA. Albumin microspheres: a unique system as drug delivery carriers for non steroidal antiinflammatory drugs.2010; 5(2):12.
23 Kalyan S, Sharma PK. Recent advancement in chitosan best formulation and its pharmaceutical application. Pelagia Research Library. 2010; 1(3):195-210.
24 Jose J, Jayapraksah V, Nayak P. Formulation and evaluation of rizatriptan matrix tablet. Research Journal of Pharmacy and Technology.2016; 9(2):115-120.
25 Charyulu RN, Devi P, Jose J. Formulation and evaluation of mucoadhesive oral gel containing miconazole nitrate for oral candidiasis. Research Journal of Pharmacy and Technology.2013;6(11):1251-1257.
26 Senthil SP et al, Formulation and evaluation of imatinib mesylate microspheres by chemical crosslinking method. Research Journal of Pharmacy and Technology.2012;5(7):934-937.
27 Hajare AA, Shetty YT. Formulation, characterization and in-vitro evaluation of floating microspheres of diltiazem hydrochloride by ionotropic gelation technique. Research Journal of Pharmacy and Technology.2008; 1(1); 52-56.
28 Ghosh A et al. Preparation, evaluation and in vitro- in vivo correlation (ivivc) study of lamivudine loaded microspheres. Research Journal of Pharmacy and Technology.2008;4(1):353-356.
29 Radhika PR, Luqman Moidutty, Borkhataria Chetan H. Preparation and evaluation of delayed release aceclofenac microspheres. Research Journal of Pharmacy and Technology. 2008; 1(3): 270-272.
30 Elayaraja A, Rao GD. Anti-Bacterial activity of various crude extracts of bryonia seabra. Research Journal of Pharmacy and Technology. 2008;1(3): 283-284.
31 Shankar BN. Preparation and in vitro evaluation of lamivudine entrapped MOI microspheres for oral administration. Research Journal of Pharmacy and Technology. 2008;1(4): 437-440.
32 Saravanakumar A et al. Polylactic acid microspheres as a potential vaccine delivery system for the tetanus toxoid: preparation and in vitro dissolution study. Research Journal of Pharmacy and Technology.2008; 1(4):453-459.
33 Garg R, Gupta GD. Development and characterization of cellulose and eudragit gastroretentive floating microspheres of acyclovir. Research Journal of Pharmacy and Technology.2009; 2(1):101-105.
34 VB Yadav, AV Yadav. Applications of chitosan in designing of different microspheres. Research Journal of Pharmacy and Technology. 2009; 2(1): 34-47.
Received on 10.11.2017 Modified on 13.12.2017
Accepted on 03.02.2018 © RJPT All right reserved
Research J. Pharm. and Tech 2018; 11(4):1681-1684.
DOI: 10.5958/0974-360X.2018.00313.X